GlassScriptPhysician profile
Tiffani A Hoefer
NPI 1093091910
$5,531.89
in general payments reported to CMS, 2019-2025
26 companies · $794 in 2025
The $794 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $710 · 2023: $2,394 · 2024: $1,059 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,295 · Travel and Lodging: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,294.70 |
| Travel and Lodging | $953.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,621.26 | 2021-2025 | Proclaim, Eterna, Octrode |
| Relievant Medsystems, INC. | $1,406.04 | 2023 | Intracept |
| Abbvie INC. | $535.52 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $346.50 | 2021-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $244.39 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Valinor Pharma, LLC | $242.41 | 2023-2025 | Movantik |
| Virtus Pharmaceuticals LLC | $158.75 | 2024-2025 | Levorphanol Tartrate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.63 | 2022-2024 | Relistor |
| Novo Nordisk INC | $99.39 | 2023 | |
| Spr Therapeutics, INC | $81.88 | 2021-2025 | Sprint Pns System |
| Almatica Pharma LLC | $70.75 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $66.53 | 2025 | |
| Globus Medical, INC. | $61.48 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $53.76 | 2021 | |
| Vertos Medical, INC. | $53.39 | 2023-2024 | Mild Device Kit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $47.58 | 2021 | |
| Grt US Holding, INC. | $41.15 | 2021 | |
| Redhill Biopharma INC. | $41.09 | 2021 | |
| Horizon Therapeutics Plc | $37.58 | 2021-2022 | |
| Si-Bone, INC. | $36.82 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $33.18 | 2024 | Horizant |
| Pfizer INC. | $30.24 | 2021 | |
| Spinal Simplicity, LLC | $25.15 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $22.53 | 2024 | Mild Device Kit |
| Lilly USA, LLC | $20.65 | 2025 | Mounjaro, Zepbound |
| Nevro Corp. | $20.24 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffani Hoefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.